OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses
Ramireddy Bommireddy, Shannon Stone, Noopur Bhatnagar, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 944-944
Open Access | Times Cited: 13
Ramireddy Bommireddy, Shannon Stone, Noopur Bhatnagar, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 944-944
Open Access | Times Cited: 13
Showing 13 citing articles:
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
Congrui Zhu, Shengmei Pang, Jiaqi Liu, et al.
Drugs (2024) Vol. 84, Iss. 4, pp. 403-423
Closed Access | Times Cited: 8
Congrui Zhu, Shengmei Pang, Jiaqi Liu, et al.
Drugs (2024) Vol. 84, Iss. 4, pp. 403-423
Closed Access | Times Cited: 8
Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?
Ki‐Back Chu, Fu‐Shi Quan
Viruses (2023) Vol. 15, Iss. 2, pp. 392-392
Open Access | Times Cited: 11
Ki‐Back Chu, Fu‐Shi Quan
Viruses (2023) Vol. 15, Iss. 2, pp. 392-392
Open Access | Times Cited: 11
From Co-Administration to Co-Formulation: The Race for New Vaccines against COVID-19 and Other Respiratory Viruses
Daniele Focosi
Vaccines (2023) Vol. 11, Iss. 1, pp. 109-109
Open Access | Times Cited: 10
Daniele Focosi
Vaccines (2023) Vol. 11, Iss. 1, pp. 109-109
Open Access | Times Cited: 10
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza
Ekaterina Stepanova, Irina Isakova-Sivak, Daria Mezhenskaya, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Ekaterina Stepanova, Irina Isakova-Sivak, Daria Mezhenskaya, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines
Yang Wang, Xiaotong Wei, Yang Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Yang Wang, Xiaotong Wei, Yang Liu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice
Bo Ryoung Park, Ramireddy Bommireddy, David Hyunjung Chung, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Bo Ryoung Park, Ramireddy Bommireddy, David Hyunjung Chung, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Multivalent and Sequential Heterologous Spike Protein Vaccinations Effectively Induce Protective Humoral Immunity against SARS-CoV-2 Variants
Rong Liu, Janhavi P. Natekar, Ki‐Hye Kim, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 362-362
Open Access | Times Cited: 1
Rong Liu, Janhavi P. Natekar, Ki‐Hye Kim, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 362-362
Open Access | Times Cited: 1
Analysis of molecular marker expression in cutaneous lesions and cervical carcinoma associated with HPV infection
Laura Maghiar, Liliana Sachelarie, Anca Huniadi
Journal of Medicine and Life (2024) Vol. 17, Iss. 6, pp. 634-638
Open Access
Laura Maghiar, Liliana Sachelarie, Anca Huniadi
Journal of Medicine and Life (2024) Vol. 17, Iss. 6, pp. 634-638
Open Access
Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters
Ekaterina Stepanova, Victoria Matyushenko, Daria A Mezhenskaia, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1300-1300
Open Access
Ekaterina Stepanova, Victoria Matyushenko, Daria A Mezhenskaia, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1300-1300
Open Access
A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV
Nan Gao, Tianhan Yang, Lanlan Dong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Nan Gao, Tianhan Yang, Lanlan Dong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
SARS-CoV-2 and Influenza A virus: Dual diagnostics and vaccines
AbdulRahman A. Saied, Manish Dhawan, Priyanka Choudhary, et al.
International Journal of Surgery (2022) Vol. 102, pp. 106653-106653
Open Access | Times Cited: 3
AbdulRahman A. Saied, Manish Dhawan, Priyanka Choudhary, et al.
International Journal of Surgery (2022) Vol. 102, pp. 106653-106653
Open Access | Times Cited: 3
Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza
Ekaterina Stepanova, Irina Isakova–Sivak, Larisa Rudenko
Expert Review of Vaccines (2022) Vol. 21, Iss. 11, pp. 1533-1535
Closed Access | Times Cited: 3
Ekaterina Stepanova, Irina Isakova–Sivak, Larisa Rudenko
Expert Review of Vaccines (2022) Vol. 21, Iss. 11, pp. 1533-1535
Closed Access | Times Cited: 3
Immunogenicity evaluation of a novel virus-like particle vaccine candidate against SARS-CoV-2 in BALB/c
Golnaz Bahramali, Maryam Mashhadi Abolghasem Shirazi, Mina Hannan, et al.
Pathogens and Disease (2023) Vol. 81
Closed Access
Golnaz Bahramali, Maryam Mashhadi Abolghasem Shirazi, Mina Hannan, et al.
Pathogens and Disease (2023) Vol. 81
Closed Access
